Mirror, Mirror on the Wall, Who's the Largest of Them All? The Features and Phenomenology of Muscle Dysmorphia

REFERENCES

• Kimmel MS. Manhood in America: a cultural history. New York: Free Press, 1996.
   Google Scholar
• Pope HG Jr, Gruber AJ, Choi P, Olivardia R, Phillips KA. Muscle dysmorphia: an underrecognized form of body dysmor- phic disorder. Psychosomatics 1997;38:548–57.
   Google Scholar
• Phillips KA, O’Sullivan RL, Pope HG Jr. Muscle dysmorphia [Letter]. J Clin Psychiatry 1997;58:361.
   PubMed Web of Science ®Google Scholar
• Olivardia R, Pope HG Jr, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry 2000;157:1291–6.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Katz DL, Hudson JI. Anorexia nervosa and “re- verse anorexia” among 108 male bodybuilders. Compr Psychi- atry 1993;34:406–9.
   Google Scholar
• Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use: a controlled study of 160 ath- letes. Arch Gen Psychiatry 1994;51:375–82.
   Google Scholar
• Pope HG Jr, Phillips KA, Olivardia R. The Adonis complex: the secret crisis of male body obsession. New York: Free Press, 2000.
   Google Scholar
• Pope HG Jr, Katz DL. Affective and psychotic symptoms asso- ciated with anabolic steroid use. Am J Psychiatry 1988;145:487–90.
   Google Scholar
• Forbes GB, Porta CR, Herr BE, Griggs RC. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA 1992;267:397–9.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Brower KJ. Psychiatric effects of anabolic- androgenic steroid use. In: Sadock BJ, Sadock VA, eds. Kaplan & Sadock’s comprehensive textbook of psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 1085–95.
   Google Scholar
• Lenders JW, Demacker PN, Vos JA, Jansen PL, Hoitsma AJ, Van ‘t Laar A, Thien T. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 1988;9:19–23.
   Google Scholar
• Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels: a literature review. Arch Intern Med 1991;151:1925–33.
   PubMed Web of Science ®Google Scholar
• Kouri EM, Pope HG Jr, Oliva PS. Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate. Clin J Sport Med 1996;6:152–7.
   Google Scholar
• McElroy SL, Phillips KA, Keck PE Jr. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1994;55(suppl):33–51.
   Google Scholar
• Phillips KA, McElroy SL, Hudson JI, Pope HG Jr. Body dys- morphic disorder: an obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychia- try 1995;56(suppl 4):41–51.
   Google Scholar
• Olivardia R. Body image and masculinity in college males. Un- published doctoral dissertation, University of Massachusetts, Boston, 2000.
   Google Scholar
• Pope HG Jr, Olivardia R, Gruber A, Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord 1999;26:65–72.
   Google Scholar
• Mishkind ME, Rodin J, Silberstein LR, Striegel-Moore RH. The embodiment of masculinity: cultural, psychological, and behavioral dimensions. Am Behav Sci 1986;29:545–62.
   Web of Science ®Google Scholar
• Wolf N. The beauty myth: how images of beauty are used against women. New York: Morrow, 1991.
   Google Scholar
• Rosenblum GD, Lewis M. The relations among body image, physical attractiveness, and body mass in adolescence. Child Dev 1999;70:50–64.
   PubMed Web of Science ®Google Scholar
• Erikson EH. Childhood and society. New York: Norton, 1950.
   Google Scholar
• Garner DM, Olmstead MP, Polivy J. Development and vali- dation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 1983;2(2): 15–34.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Ameri- can Psychiatric Association, 1994.
   Google Scholar
• Neziroglu FA, Yaryura-Tobias JA. Exposure, response preven- tion, and cognitive therapy in the treatment of body dysmor- phic disorder. Behav Ther 1993;24:431–8.
   Google Scholar
• Rosen JC, Reiter J, Orosan P. Cognitive-behavioral body im- age therapy for body dysmorphic disorder. J Consult Clin Psy- chol 1995;63:263–9.
   PubMed Web of Science ®Google Scholar
• Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther 1996;34:717–29.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behav- ior group therapy for body dysmorphic disorder: a case series. Behav Res Ther 1999;37:71–5.
   Google Scholar
• Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press, 1976.
   Google Scholar
• Phillips KA, Dwight MM, McElroy S. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 1998;59:165–71.
   PubMed Web of Science ®Google Scholar
• Phillips KA. Pharmacologic treatment of body dysmorphic dis- order: a review of empirical data and a proposed treatment algorithm. Psychopharm Bull 1996;32:597–605.
   PubMedGoogle Scholar
• Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999;56:1033–9.
   PubMed Web of Science ®Google Scholar